BCIMC
GRCL

Boyu Capital Investment Management Company’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Boyu Capital Investment Management Company’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-127,605
Closed -$1.97M – 9
2021
Q1 		$1.97M Buy
+127,605
New +$3.01M 0.4% 6

Other funds holding GRCL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
CloudAlpha Capital Management Hong Kong $3.51B AUM 530.07% 1-Year Est. Return

Boyu Capital Investment Management Company's GRCL Position: Q2 2021 in Review

Boyu Capital Investment Management Company sold out of Gracell Biotechnologies Inc. American Depositary Shares (GRCL) in Q2 2021, closing a stake of 127,605 shares — an estimated $1.97M sold.

Boyu Capital Investment Management Company first reported a position in GRCL in Q1 2021 and held it in 1 quarter. The position peaked at $1.97M in Q1 2021. 32 funds tracked by Wall St. Rank hold GRCL as of Q2 2021.

  • Boyu Capital Investment Management Company reported no remaining Gracell Biotechnologies Inc. American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Boyu Capital Investment Management Company sold 127,605 Gracell Biotechnologies Inc. American Depositary Shares shares in Q2 2021, an estimated $1.97M.
  • Boyu Capital Investment Management Company first reported a position in Gracell Biotechnologies Inc. American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Boyu Capital Investment Management Company's Gracell Biotechnologies Inc. American Depositary Shares position peaked at $1.97M in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Gracell Biotechnologies Inc. American Depositary Shares as of Q2 2021.

Based on Boyu Capital Investment Management Company's 13F filing for Q2 2021, filed 13 Aug 2021.